Release Notes for 2026-07-26: Number of new affinity data: 7774 Number of compounds (ligands) new to BindingDB: 4014 Number of Targets new to BindingDB: 12 New Targets: Cyclin-dependent kinase 5 activator 1 (CDK5-P25) (Q15078): 6 inhibitors DNA mismatch repair protein Mlh1 (P40692): 95 inhibitors GTPase KRas (G12D) (P01116[G12D]): 6 inhibitors Glutathione S-transferase class-mu 26 kDa isozyme/Bcl-2-like protein 1 [2-209] (P08515,Q07817[2-209]): 35 inhibitors Menin [2-610] (O00255[2-610]): 183 inhibitors Poly [ADP-ribose] polymerase 2 (PARP2) (Q9UGN5): 1 inhibitors Protein Cereblon/Bromodomain-containing protein 3 (Q15059,Q96SW2): 3 inhibitors Protein mono-ADP-ribosyltransferase TIPARP (PARP7) (Q7Z3E1): 1 inhibitors Small VCP/p97-interacting protein (Q8NHG7): 156 inhibitors Transcriptional enhancer factor TEF-3 (Tead4) (Q15561): 22 inhibitors Transcriptional enhancer factor TEF-4 (Tead2) (Q15562): 11 inhibitors Transcriptional enhancer factor TEF-5 (Tead3) (Q99594): 9 inhibitors Number of new Entries: 63 PubMed id or Patent id Title US12552758 Inhibitors of MLH1 and/or PMS2 for cancer treatment US12552793 Purine derivative and medical use thereof US12552795 Pyrrolotriazine derivatives for treating kit-and PDGFRA-mediated diseases US12552798 Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors US12552799 Triazolone compounds US12552811 Immunosuppressant, and preparation method therefor and use thereof US12558356 Immunophilin binding agents and uses thereof US12559471 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof US12559480 Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase US12559487 Crosslinked optically active secondary amine derivative US12565476 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors US12565480 Thiophene derivatives as xanthine oxidase inhibitors and application thereof US12565481 6,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET US12565492 Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof US12565495 VMAT2 inhibitor and preparation method therefor and application thereof US12565497 Sulfone derivatives US12565500 Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors US12565502 Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitors US12565504 Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors US12570607 Compound as cyclin-dependent kinase 9 inhibitor and use thereof US12570614 Phenyl amino pyrimidine compounds and uses thereof US12570631 Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk US12570646 Compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same US12570648 6,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancer US12570659 Bicyclic heteroaryl compounds useful as IRAK4 inhibitors US12570673 c-Myc protein inhibitor, and preparation method therefor and use thereof US12570675 Boronic acid compounds US20210101879 AMYLOID PROTEIN-SELECTIVE BACE INHIBITORS (ASBIs) FOR ALZHEIMER'S DISEASE US20260042747 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF US20260049068 Substituted Tetrazolyl Compounds Useful as T Cell Activators US20260049071 PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF US20260049077 Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using Same US20260049078 DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS US20260049082 AMIDO PYRIDO[3,4-B]INDOLE-1,4-DIONE COMPOUNDS FOR TREATMENT OF PORPHYRIAS US20260049084 ENPP1 MODULATORS AND PRODUCTS AND USES THEREOF US20260049089 KRAS INHIBITOR COMPOUND US20260055061 HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION US20260055079 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS US20260055088 HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF US20260055093 NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF US20260055102 PYRIDO-PYRAZOLES AS INHIBITORS OF DDR'S FOR THE TREATMENT OF FIBROTIC DISORDERS AND CANCER US20260055104 CRYSTAL FORM OF HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOF US20260055107 SERIES OF NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUNDS AND PREPARATION METHOD THEREFOR US20260055108 TRIAZINE COMPOUNDS AND USES THEREOF US20260055113 HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER US20260055120 Bicyclic pyrimidinones as inhibitors of NOX4 US20260055126 SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF US20260060961 SUBSTITUTED HETEROCYCLES AS RAS INHIBITORS US20260062376 SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS US20260062387 SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME US20260062412 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY US20260062420 NOVEL DPP1 INHIBITORS AND USES THEREOF US20260069571 DDR1 AND DDR2 INHIBITORS FOR THE TREATEMENT OF CANCER AND FIBROTIC DISEASES US20260070878 TNKS2 INHIBITORS US20260070885 TRKA (G667C) AND FLT3 TARGET INHIBITOR AND COMBINATION OF SAME WITH CHIDAMIDE US20260070887 AMIDE OR UREA COMPOUND US20260070888 7-ALKOXYQUINOLINES AS MODULATORS OF POLRMT US20260070901 NOVEL COMPOUNDS AS CK2 INHIBITORS US20260070914 SUBSTITUTED PYRROLO[2,1-F][1,2,4]TRIAZIN-2-AMINES AS CDK2 AND CDK4 INHIBITORS US20260070915 SUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINES AS SELECTIVE CDK2/4 INHIBITORS US20260070918 HETEROBICYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS US20260070924 INDAZOLE MACROCYCLES AND THEIR USE US20260070927 INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE